It's High Time For The Cannabis-Related Drug Pipeline

Zynerba Pharmaceuticals, Inc (NASDAQ: ZYNE) gave investors an update on its clinical program this week. Like weeds, specialty pharmaceutical ...

read more here
Delivered by @can_nab_is